Heshui S. Wu
Union Hospital
Wuhan, 430022, China
Wuhan, 430022, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 143 publications
The surgical outcomes of modified Chen's U-suture technique compared with duct-to-mucosa anastomosis in laparoscopic pancreaticoduodenectomy: a multi-center cohort study.
Journal: Surgical endoscopy
Published: February 21, 2026
Neoadjuvant Early Stereotactic Body Radiation Therapy Followed by Chemoimmunotherapy in Borderline Resectable and Locally Advanced Pancreatic Cancer.
Journal: Advances in radiation oncology
Published: February 10, 2026
Impact of age on safety of pancreaticoduodenectomy: a nationwide cohort study stratified by surgical approach and anastomotic technique with optimal age cut-off analysis.
Journal: Science China. Life sciences
Published: February 10, 2026
RNF43 deficiency activates YBX1-MYC-driven oxidative phosphorylation in pancreatic cancer.
Journal: Cancer letters
Published: January 25, 2026
HDAC1 Regulates Acquired Resistance to EGFR Inhibitors through the TFCP2-NDRG1 Signaling Axis in Pancreatic Cancer.
Journal: International journal of biological sciences
Published: January 06, 2026
A Modified Chen's U-Suture Technique with or Without a Stent in Pancreaticojejunostomy for Patients with Soft Pancreas and Small Pancreatic Duct: A Multicenter Cohort Study.
Journal: Journal of investigative surgery : the official journal of the Academy of Surgical Research
Published: December 03, 2025
E2F3 activates NF-κB signaling through TRIM26 mediated TAB1 ubiquitination in pancreatic cancer.
Journal: International journal of biological sciences
Published: November 02, 2025
NALIRIFOX versus gemcitabine plus nab-paclitaxel in Chinese patients with advanced pancreatic adenocarcinoma: a randomized, open-label phase II trial.
Journal: Nature communications
Published: August 28, 2025
CK2-mediated HDAC5 shuttling regulates DNA end resection through Ku70 deacetylation.
Journal: Theranostics
Published: August 02, 2025
An explainable prediction model for lymphovascular invasion and its prognostic value in resected pancreatic ductal Adenocarcinoma:A two-center study.
Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
Published: July 17, 2025
Tecotabart vedotin in Claudin 18.2-positive advanced gastric/gastroesophageal junction cancer: A Bayesian phase 1/2 clinical trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 11, 2025
Implementation of personalized T-cell therapy in the treatment of pancreatic cancer
Journal: Zhonghua wai ke za zhi [Chinese journal of surgery]
Published: June 25, 2025
Last Updated: 09/26/2026